Director of Catherization Laboratory and Head of Structural Heart Interventions Program
Poznan University of Medical Sciences
Poznan, Poland
Prof. Marek Grygier is Director of Catherization Laboratory and Head of Structural Heart Interventions Program and Professor at Poznan University of Medical Sciences, Poznan, Poland. He is currently the President of Association for Cardiovascular Interventions of Polish Cardiac Society and also the Board Member and Pilar Chair of the Scientific Programme and Congress Committee, European Association of Percutaneous Cardiovascular Interventions (EAPCI). He is an interventional cardiologist with over 20 years of experience in the field. His main research interest is structural heart interventions including TAVR, TEER, TMVR, LAAC, ASD, PFO, VSD etc.. He has performed a series of studies in this area and has taken part in many clinical trials.
Saturday, February 25, 2023
8:00 AM – 9:00 PM ET
Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Grants/Research Support Recipient (Ongoing); Abbott: Consultant/Advisory Board (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Educational Grant (Ongoing), Grants/Research Support Recipient (Ongoing), Scientific Advisory Board (Ongoing); Boston Scientific: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing), Educational Grant (Ongoing), Grant/Research Support (Ongoing), Honoraria (Ongoing), Scientific Advisory Board (Ongoing), Scientific Research Study Investigator (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing), Educational Grant (Ongoing), Grant Recipient (Ongoing), Scientific Advisory Board (Ongoing)
Sunday, February 26, 2023
8:00 AM – 9:00 PM ET
Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Grants/Research Support Recipient (Ongoing); Abbott: Consultant/Advisory Board (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Educational Grant (Ongoing), Grants/Research Support Recipient (Ongoing), Scientific Advisory Board (Ongoing); Boston Scientific: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing), Educational Grant (Ongoing), Grant/Research Support (Ongoing), Honoraria (Ongoing), Scientific Advisory Board (Ongoing), Scientific Research Study Investigator (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing), Educational Grant (Ongoing), Grant Recipient (Ongoing), Scientific Advisory Board (Ongoing)
Monday, February 27, 2023
8:00 AM – 9:00 PM ET
Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Grants/Research Support Recipient (Ongoing); Abbott: Consultant/Advisory Board (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Educational Grant (Ongoing), Grants/Research Support Recipient (Ongoing), Scientific Advisory Board (Ongoing); Boston Scientific: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing), Educational Grant (Ongoing), Grant/Research Support (Ongoing), Honoraria (Ongoing), Scientific Advisory Board (Ongoing), Scientific Research Study Investigator (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing), Educational Grant (Ongoing), Grant Recipient (Ongoing), Scientific Advisory Board (Ongoing)